| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.39 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |